Latest Press Releases
"Join Entrada if you’d like to be a part of developing novel therapeutics that have the potential to fundamentally improve the standard-of-care in serious diseases."
Natarajan Sethuraman, PhD, Chief Scientific Officer
TIDES USA 2021: Oligonucleotides and Peptide TherapeuticsHybrid (Boston, MA)Sep 20-23, 2021
Sep 20-24, 2021
Sep 26-29, 2021
Finalist for the Xconomy Awards 2019 Startup
BioSpace Top Life Sciences Startup to Watch in 2020